FZata
Chemicals & Related Products · Maryland, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1450 S Rolling Rd, Halethorpe, Maryland,...Phone Number
(443) 543-5040Website
www.fzata.comRevenue
<$5 MillionIndustry
About FZata
FZata Org Chart
Is FZata your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if FZata had a recent Job posting/layoffs
Check out if FZata is spiking on competitors!
Funding: Get notified immidiatlly once FZata has new funding data
FZata, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on FZata recently announced quarterly report
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when FZata launches new products
Congratulate Masked Content for being promoted to Masked Content at FZata
Check if FZata has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at FZata
Find 2 more new buyers
Compare Similar Companies to FZata
Compare insights from companies similar to FZata, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
FZata is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
FZata is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about FZata.
FZata Tech Stack
A closer look at the technologies used by FZata
FZata News & Media
Fzata to Attend BIO International Convention 2025
HALETHORPE, Md., May 16, 2025 /PRNewswire/ -- Fzata, Inc., a near clinical-stage biotechnology company developing oral biologics for GI disorders, announces it will attend the BIO International Convention 2025 in Boston. The goal is to identify a pharma partner for FZ006 a preclinical...C. difficile Clinical Trial Agreement for Fzata's FZ002
HALETHORPE, Md., March 11, 2025 /PRNewswire/ -- Fzata, Inc. announces the execution of a clinical trial agreement with the National Institutes of Health (NIH) to sponsor a Phase 1 clinical trial of FZ002 for C. difficile treatment. Oral FZ002 is a live yeast genetically modified to...Fzata, Inc. Announces Multi-million Dollar NIH Grant
HALETHORPE, Md., Sept. 24, 2024 /PRNewswire/ -- Fzata, Inc. is pleased to announce a five-year UG3/UH3 non-dilutive grant (UG3NS135350) of up to $7 million, plus in-kind contributions, awarded by the NIH National Institute of Neurological Disorders and Stroke (NINDS). Grant participants...Fzata is a Start-Up Stadium Finalist at BIO 2024
HALETHORPE, Md., May 14, 2024 /PRNewswire/ -- Fzata, Inc. is honored to be selected as a finalist to pitch at Start-Up Stadium during the BIO2024 International Convention, San Diego, CA, June 3-6. BIO will host over 20,000 industry leaders from across the globe. Start-Up Stadium is...
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding FZata
Fzata, Inc. is a preclinical oral biologics therapeutics company based in Maryland. They specialize in developing proprietary Bioengineered Probiotic Yeast Medicines (BioPYM®) that utilize live yeast to create therapeutics targeting gastrointestinal disorders. Their innovative platform represents a first-in-class approach to oral live biotherapeuti... Read More